Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.
about
Nanoprobes visualizing gliomas by crossing the blood brain tumor barrier.Use of Nanotechnology to Develop Multi-Drug Inhibitors For Cancer TherapyBioengineering strategies for designing targeted cancer therapiesPoly Ethoxy Ethyl Glycinamide (PEE-G) Dendrimers: Dendrimers Specifically Designed for Pharmaceutical Applications.Biologically optimized nanosized molecules and particles: more than just size.Inhibiting bacterial toxins by channel blockage.COMPARATIVE PHARMACOKINETICS OF PAMAM-OH DENDRIMERS AND HPMA COPOLYMERS IN OVARIAN-TUMOR-BEARING MICEImpact of molecular weight on lymphatic drainage of a biopolymer-based imaging agentDendrimer pharmacokinetics: the effect of size, structure and surface characteristics on ADME properties.Multifunctional dendritic polymers in nanomedicine: opportunities and challenges.Transdermal drug delivery: from micro to nano.Image-guided nanosystems for targeted delivery in cancer therapy.Engineering Gd-loaded nanoparticles to enhance MRI sensitivity via T(1) shortening.The Janus face of PAMAM dendrimers used to potentially cure nonenzymatic modifications of biomacromolecules in metabolic disorders-a critical review of the pros and cons.Nanoparticulate carriers: an emerging tool for breast cancer therapy.Dendritic glycopolymers based on dendritic polyamine scaffolds: view on their synthetic approaches, characteristics and potential for biomedical applications.Recent advances in targeted drug delivery approaches using dendritic polymers.Surface charge and particle size determine the metabolic fate of dendritic polyglycerols.Multivalent Inhibitors of Channel-Forming Bacterial Toxins.MRI of ICAM-1 upregulation after stroke: the importance of choosing the appropriate target-specific particulate contrast agent.Star-shaped polymer consisting of a porphyrin core and poly(L-lysine) dendron arms: synthesis, drug delivery, and in vitro chemo/photodynamic therapy.Physiologically based pharmacokinetic model for composite nanodevices: effect of charge and size on in vivo disposition.Cationic PAMAM dendrimers as pore-blocking binary toxin inhibitors.Low-Level Detection of Poly(amidoamine) PAMAM Dendrimers Using Immunoimaging Scanning Probe Microscopy.Thermal Stimuli-Triggered Drug Release from a Biocompatible Porous Metal-Organic Framework.Analysis of biotinylated generation 4 poly(amidoamine) (PAMAM) dendrimer distribution in the rat brain and toxicity in a cellular model of the blood-brain barrier.A multifunctional metal-organic framework based tumor targeting drug delivery system for cancer therapy.Dendrosome-dendriplex inside liposomes: as a gene delivery system.Dendrimeric systems and their applications in ocular drug delivery.Dendrimers in RNAi DeliveryDendrimers as Powerful Building Blocks in Central Nervous System Disease: Headed for Successful NanomedicineImpact of maltose modified poly(propylene imine) dendrimers on liver alcohol dehydrogenase (LADH) internal dynamics and structure
P2860
Q30672749-A7EEFFC6-3D61-4699-83AE-DB844AEAE839Q33859472-305C2A87-7114-4413-994E-6F014829EDA6Q34194191-B16A5E9F-341D-4CC9-BDC3-AEF6FC9D9B69Q34533387-3F1F19B2-E633-4E79-9BB3-1CAFBB22CDC6Q35048175-E77875F5-BB00-49D0-9600-DAA3D3A0CCE1Q36794160-758AEA4C-8B83-4DAE-BA9E-5419DF8D0DFAQ36936207-4EBEA055-9BD8-4A0F-8B3F-32EBA3308A00Q37327825-59979638-9271-4399-9D30-552CA7384F1BQ37939967-49F26D27-4847-4C12-8040-FB3E1069AB7EQ37967150-78DA4A42-9E4B-4523-9A74-875D91CE861DQ37984016-BF35CEBF-65B8-4A45-A86D-8D2F067A3B96Q38011794-F7F9A230-135E-4753-8D8A-3A972A18D3D6Q38155457-D80AD3DC-559B-477D-A410-BB2751250C9FQ38161415-C8BAABD3-A2E6-4379-95B1-A747FB029E9BQ38250517-F63D35F3-2E88-4B75-950F-EA40CA2C2098Q38292341-E6A3E5F1-DD46-4DA4-986C-5B6622C76BFBQ38556761-36182258-7E18-43ED-B947-04008D6439EDQ38724798-EB86BD3F-FC95-49B9-8CF4-30CF752B3950Q38911726-CC23BBC4-42BF-4033-A576-1A5200EFE823Q39196364-DB549B09-6CD5-405A-89BF-6A9E0AF154E7Q39198828-B1678AF7-2859-40D1-9FD4-08D833B9A663Q39332969-2A2109EF-7985-412F-88A7-621C47E19368Q41901324-72EC2855-6C0E-49F9-8E30-4D914BD3D89FQ42230140-24E90CA5-2CCF-4FEB-BF65-902E1D5491E7Q47954054-CEADCE99-7B6E-4EA2-8D58-4DFBB5A8C82EQ49017113-D0D53597-4BA5-4F47-9BEF-326BD814BDC8Q50245528-8239825B-2519-497C-9BFF-121B0420099BQ50268214-37E6770A-8EB4-48A3-86F8-4305458ADD67Q55563721-3AF71931-A868-440F-B8D6-F95E9AF90E9EQ57079937-BECCD576-932C-4628-A256-92ECD650034DQ57556323-041E1128-4606-4626-B874-3E87362D588FQ57777311-18D8977B-E527-4B07-936D-306B9E5098F1
P2860
Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.
@en
Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.
@nl
type
label
Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.
@en
Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.
@nl
prefLabel
Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.
@en
Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.
@nl
P2093
P2860
P1476
Designing dendrimers for drug delivery and imaging: pharmacokinetic considerations.
@en
P2093
Mitsuru Hashida
Shigeru Kawakami
Wassana Wijagkanalan
P2860
P304
P356
10.1007/S11095-010-0339-8
P577
2010-12-23T00:00:00Z